Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

SNS-032 shows moderate activity in phase I trial in B-cell malignancies

Aug. 10, 2010

Curis provides update on phase II vismodegib trial in advanced ovarian cancer

Aug. 10, 2010

Aragon doses first patient in phase I/II ARN-509 trial in prostate cancer

Aug. 10, 2010

Cannabidiol displays antiangiogenic activity in preclinical tests

Aug. 10, 2010

Sunesis partners for phase III VALOR trial of vosaroxin in AML

Aug. 9, 2010

FDA does not grant orphan drug status to Levulan PDT for SCC prevention

Aug. 9, 2010

Glycotope begins phase I trial of GT-MAb 5.2-GEX in cancer

Aug. 9, 2010

Clavis advances phase II gemcitabine elaidate trial in pancreatic cancer

Aug. 9, 2010

Italian scientists identify new EGFR inhibitors

Aug. 9, 2010

Cornerstone Pharma adds new site for phase I/II CPI-613 trials in cancer

Aug. 9, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...